DeSmet M - Search Results

1

Pharmacokinetics of intravenous alendronate.

Cocquyt V, Kline WF, Gertz BJ, Van Belle SJ, Holland SD, DeSmet M, Quan H, Vyas KP, Zhang KE, De Grève J, Porras AG. Cocquyt V, et al. Among authors: desmet m. J Clin Pharmacol. 1999 Apr;39(4):385-93. doi: 10.1177/00912709922007958. J Clin Pharmacol. 1999. PMID: 10197297 Clinical Trial.

2

Effect of rofecoxib on the pharmacokinetics of digoxin in healthy volunteers.

Schwartz JI, De Smet M, Larson PJ, Verbesselt R, Ebel DL, Lins R, Lens S, Porras AG, Gertz BJ. Schwartz JI, et al. J Clin Pharmacol. 2001 Jan;41(1):107-12. doi: 10.1177/00912700122009755. J Clin Pharmacol. 2001. PMID: 11144988 Clinical Trial.

3

Cellular pharmacokinetics of vinblastine and other vinca alkaloids in MO4 cells.

Van Belle SJ, De Smet MC, De Mey JE, Storme GA. Van Belle SJ, et al. Anticancer Res. 1991 Jan-Feb;11(1):465-71. Anticancer Res. 1991. PMID: 2018383

4

The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.

Schwartz JI, Bugianesi KJ, Ebel DL, De Smet M, Haesen R, Larson PJ, Ko A, Verbesselt R, Hunt TL, Lins R, Lens S, Porras AG, Dieck J, Keymeulen B, Gertz BJ. Schwartz JI, et al. Clin Pharmacol Ther. 2000 Dec;68(6):626-36. doi: 10.1067/mcp.2000.112244. Clin Pharmacol Ther. 2000. PMID: 11180023 Clinical Trial.

5

Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis.

Cocquyt V, Van Belle S, Reinhardt RR, Decramer ML, O'Brien M, Schellens JH, Borms M, Verbeke L, Van Aelst F, De Smet M, Carides AD, Eldridge K, Gertz BJ. Cocquyt V, et al. Eur J Cancer. 2001 May;37(7):835-42. doi: 10.1016/s0959-8049(00)00416-0. Eur J Cancer. 2001. PMID: 11313170 Clinical Trial.

6

Influence of beta-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol.

Goldberg MR, Sciberras D, De Smet M, Lowry R, Tomasko L, Lee Y, Olah TV, Zhao J, Vyas KP, Halpin R, Kari PH, James I. Goldberg MR, et al. Br J Clin Pharmacol. 2001 Jul;52(1):69-76. doi: 10.1046/j.0306-5251.2001.01417.x. Br J Clin Pharmacol. 2001. PMID: 11453892 Free PMC article. Clinical Trial.

7

Increasing peak levels of vinblastine given in repeated divided doses.

Van Belle SJ, de Smet MC, De Mey JE, De Neve W, Massart DL, Storme G. Van Belle SJ, et al. Anticancer Res. 1992 May-Jun;12(3):655-9. Anticancer Res. 1992. PMID: 1622122

8

Interaction between vinblastine and ionizing radiation in the mouse MO4 fibrosarcoma in vivo.

Van Belle S, Fortan L, De Smet M, De Neve W, Van der Elst J, Storme G. Van Belle S, et al. Anticancer Res. 1994 May-Jun;14(3A):1043-8. Anticancer Res. 1994. PMID: 8074448

9

Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females.

Cheng H, Leff JA, Amin R, Gertz BJ, De Smet M, Noonan N, Rogers JD, Malbecq W, Meisner D, Somers G. Cheng H, et al. Pharm Res. 1996 Mar;13(3):445-8. doi: 10.1023/a:1016056912698. Pharm Res. 1996. PMID: 8692739 Clinical Trial.

10

Single dose pharmacokinetics, safety and tolerability of MK-0476, a new leukotriene D4-receptor antagonist, in healthy volunteers.

Schoors DF, De Smet M, Reiss T, Margolskee D, Cheng H, Larson P, Amin R, Somers G. Schoors DF, et al. Br J Clin Pharmacol. 1995 Sep;40(3):277-80. doi: 10.1111/j.1365-2125.1995.tb05785.x. Br J Clin Pharmacol. 1995. PMID: 8527292 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters